DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name ▲ | Gene Symbol | Gene ID | Gene Name | UniProt ID |
---|---|---|---|---|---|
C1306459 | Primary malignant neoplasm | CEACAM6 | 4680 | CEA cell adhesion molecule 6 | P40199 |
C1306459 | Primary malignant neoplasm | ARSF | 416 | arylsulfatase F | P54793 |
C1306459 | Primary malignant neoplasm | MTM1 | 4534 | myotubularin 1 | Q13496 |
C1306459 | Primary malignant neoplasm | OLR1 | 4973 | oxidized low density lipoprotein receptor 1 | P78380 |
C1306459 | Primary malignant neoplasm | ALDH7A1 | 501 | aldehyde dehydrogenase 7 family member A1 | P49419 |
C1306459 | Primary malignant neoplasm | OXCT1 | 5019 | 3-oxoacid CoA-transferase 1 | P55809 |
C1306459 | Primary malignant neoplasm | OPCML | 4978 | opioid binding protein/cell adhesion molecule like | Q14982 |
C1306459 | Primary malignant neoplasm | PIK3CB | 5291 | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta | P42338 |
C1306459 | Primary malignant neoplasm | HSD17B7 | 51478 | hydroxysteroid 17-beta dehydrogenase 7 | P56937 |
C1306459 | Primary malignant neoplasm | ENPP2 | 5168 | ectonucleotide pyrophosphatase/phosphodiesterase 2 | Q13822 |
C1306459 | Primary malignant neoplasm | PCYT1A | 5130 | phosphate cytidylyltransferase 1, choline, alpha | P49585 |
C1306459 | Primary malignant neoplasm | HSD17B12 | 51144 | hydroxysteroid 17-beta dehydrogenase 12 | Q53GQ0 |
C1306459 | Primary malignant neoplasm | PAFAH1B2 | 5049 | platelet activating factor acetylhydrolase 1b catalytic subunit 2 | P68402 |
C1306459 | Primary malignant neoplasm | PAFAH1B1 | 5048 | platelet activating factor acetylhydrolase 1b regulatory subunit 1 | P43034 |
C1306459 | Primary malignant neoplasm | PIK3CG | 5294 | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | P48736 |
C1306459 | Primary malignant neoplasm | PKD1 | 5310 | polycystin 1, transient receptor potential channel interacting | P98161 |
C1306459 | Primary malignant neoplasm | PKD2 | 5311 | polycystin 2, transient receptor potential cation channel | Q13563 |
C1306459 | Primary malignant neoplasm | PLD1 | 5337 | phospholipase D1 | Q13393 |
C1306459 | Primary malignant neoplasm | PLA2G1B | 5319 | phospholipase A2 group IB | P04054 |
C1306459 | Primary malignant neoplasm | PLAUR | 5329 | plasminogen activator, urokinase receptor | Q03405 |
C1306459 | Primary malignant neoplasm | PLCB2 | 5330 | phospholipase C beta 2 | Q00722 |
C1306459 | Primary malignant neoplasm | PLCD1 | 5333 | phospholipase C delta 1 | P51178 |
C1306459 | Primary malignant neoplasm | PLCB4 | 5332 | phospholipase C beta 4 | Q15147 |
C1306459 | Primary malignant neoplasm | PRKAA2 | 5563 | protein kinase AMP-activated catalytic subunit alpha 2 | P54646 |
C1306459 | Primary malignant neoplasm | LY6K | 54742 | lymphocyte antigen 6 family member K | Q17RY6 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024